Evidence map›Paper›PMID 35463093›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Lupeol Stearate Accelerates Healing and Prevents Recurrence of Gastric Ulcer in Rodents.

Lincon Bordignon Somensi, Philipe Costa, Thaise Boeing, Luísa Nathália Bolda Mariano, Elizama de Gregório, Aline Teixeira Maciel E Silva, Bruna Longo, Claudriana Locatelli, Priscila de Souza, Cássia Gonçalves Magalhães and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Protective effect ofMicrobiology spectrum · 2024
    Article
  6. Article
  7. Article
  8. Lupeol Stearate Accelerates Healing and Prevents Recurrence of Gastric Ulcer in Rodents.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Lincon Bordignon SomensiPrograma de Pós-Graduação em Desenvolvimento e Sociedade (PPGDS), Universidade Alto Vale do Rio do Peixe, CEP, 89500-199 Caçador, SC, Brazil.
Philipe CostaPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.
Thaise BoeingPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.ORCID https://orcid.org/0000-0002-3793-6166
Luísa Nathália Bolda MarianoPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.
Elizama de GregórioPrograma de Pós-Graduação em Desenvolvimento e Sociedade (PPGDS), Universidade Alto Vale do Rio do Peixe, CEP, 89500-199 Caçador, SC, Brazil.
Aline Teixeira Maciel E SilvaDepartamento de Química, Centro de Ciências Exatas e Naturais, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Bruna LongoPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.
Claudriana LocatelliPrograma de Pós-Graduação em Desenvolvimento e Sociedade (PPGDS), Universidade Alto Vale do Rio do Peixe, CEP, 89500-199 Caçador, SC, Brazil.
Priscila de SouzaPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.
Cássia Gonçalves MagalhãesDepartamento de Química, Centro de Ciências Exatas e Naturais, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brazil.
Lucienir Pains DuarteDepartamento de Química, Centro de Ciências Exatas e Naturais, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Luisa Mota da SilvaPrograma de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Núcleo de Investigacões Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai, 458, Centro, 88302-202 Itajaí, SC, Brazil.ORCID https://orcid.org/0000-0001-5329-7301
Universidade do Vale do Itajaí · BRUniversidade Federal de Minas Gerais · BRUniversity Alto Vale do Rio do Peixe · BRUniversidade Estadual de Ponta Grossa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The focus of this study was to evaluate the gastric healing effect of lupeol stearate (LS) and its ability to minimize ulcer recurrence in rodents. Methods: To evaluate the gastric healing properties of LS, rats were subjected to 80% acetic acid-induced ulcer model and treated with vehicle, LS (1 mg/kg, p.o.), or omeprazole (20 mg/kg, p.o.), twice daily by seven days. The gastric ulcers were evaluated macroscopically, histologically, and biochemically. To evaluate the effects of LS in gastric ulcer recurrence, mice were ulcerated with 10% acetic acid and treated with vehicle, LS (1 mg/kg, p.o.), or ranitidine (100 mg/kg, p.o.), twice a day for ten days. Then, ulcer recurrence in these animals was induced by IL-1 Results: The oral treatment with LS accelerated gastric healing by 63% in rats compared to the vehicle group, evidenced by histological improvement and increased gastric mucin levels. Moreover, the gastric healing effects of LS in rats were accompanied by an elevation in glutathione S-transferase activity and a reduction in myeloperoxidase activity. Furthermore, the LS treatment reduced the recurred lesions in mice. Conclusions: The oral treatment of LS accelerates gastric healing in rats by favoring mucus production and reducing neutrophil migration, and it also can reduce ulcer recurrence. These data highlighted this compound as promising for developing new pharmacological strategies for the management of gastric ulcer.

Identifiers

PMID35463093
PMCPMC9020945
OpenAlexW4226075360

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.